RS Research is a biotechnology startup specializing in developing smart drugs based on nanotechnology for precise chemotherapy targeting. The company aims to enhance the effectiveness of chemotherapy and reduce its side effects using its proprietary Sagitta® technology. Established in 2015 as a joint venture with Boğaziçi University, RS Research focuses on creating innovative therapeutic solutions to support cancer patients.